Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study

H Singh, E Arora, S Narula, M Singla… - Expert Review of …, 2023 - Taylor & Francis
Objective To identify a preferred and cost-effective drug among Dipeptidyl peptidase-4
inhibitors (DPP4Is) for Indian patients with T2DM. Methods We performed a systematic …

[PDF][PDF] The eminent threats of counterfeit drugs to quality health care delivery in Africa: updates on consequences and way forward

N Aminu, MS Gwarzo - Asian Journal of Pharmaceutical and …, 2017 - researchgate.net
Counterfeit drugs (CDs) continue to cause serious public health problems in many countries
around the globe, particularly in the African countries which are their major consumers. Soft …

Availability, prices and affordability of antibiotics stocked by informal providers in rural India: a cross-sectional survey

M Gautham, R Miller, S Rego, C Goodman - Antibiotics, 2022 - mdpi.com
Providers without formal training deliver healthcare and antibiotics across rural India, but
little is known about the antibiotics that they stock. We conducted a cross-sectional survey of …

[HTML][HTML] Health system interventions for the cost containment of drugs used for cardiovascular diseases: a systematic review and exploration of how the results could …

JLP Chaminda, S Kularatna… - Global Health …, 2024 - Elsevier
Objectives Cardiovascular disease (CVD) in low and middle-income countries (LMICs),
accounts for over 80% of global CVD-related deaths. The high cost of drugs is a major …

[HTML][HTML] An analysis of the cost variation among different antimicrobial agents: The Indian scenario

A Shah, C Patel, P Shah, J Patel, B Sojitra, S Pandya… - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Background and objective Infectious diseases pose a substantial global health challenge,
especially in developing countries where healthcare accessibility is limited. Pharmaceutical …

Impact of price control on pharmaceutical sector with reference to India

A Kolte, H Mal, M Fulambrikar… - International Journal of …, 2021 - inderscienceonline.com
In India, drug prices are controlled and are commonly known as Drug Price Control Orders
(DPCO) issued under the Indian Essential Commodities Act of 1955. It is governed by the …

[HTML][HTML] Cost of treating bacterial infections in India: a cost minimization analysis to assess price variations

S Atal, A Mathur… - Biomedical and …, 2020 - biomedpharmajournal.org
Cost of drug therapy is a major concern for patients in developing countries. Indian
government has launched a generic drug ('Jan Aushadhi') scheme to provide cheaper …

Performance Analysis of the Indian Pharmaceutical Industry: A Global Outlook

C Chakraborty, D Pal - 2025 - emerald.com
Banker, RD, & Natarajan, R.(2008). Evaluating contextual variables affecting productivity
using data envelopment analysis. Operations Research, 56 (1), 48–58. Banker, RD …

[PDF][PDF] Drug price control order: the impact on pharmacoeconomics

SM Shah, AP Singh, PK Vachhani - International Journal of Basic & …, 2019 - academia.edu
Background: The objective of the present study was to analyze the prices of metformin,
losartan, atorvastatin, paracetamol and aspirin for the doses which are included in the list of …

Comparative evaluation of bioburden and sterility of indigenously prepared bone allograft with and without gentamicin

K Makker, AK Lamba, F Faraz, S Tandon… - Cell and Tissue …, 2019 - Springer
During bone allograft processing, despite stringent donor screening and use of aseptic
techniques, microbial invasion may occur due to the porous nature of the graft and cause …